相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Low Fecal Calprotectin Predicts Sustained Clinical Remission in Inflammatory Bowel Disease Patients: A Plea for Deep Remission
Erik Mooiweer et al.
JOURNAL OF CROHNS & COLITIS (2015)
Adalimumab Induces Deep Remission in Patients With Crohn's Disease
Jean-Frederic Colombel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
Simon P. L. Travis et al.
GUT (2014)
Histologic Evaluation of Ulcerative Colitis: A Systematic Review of Disease Activity Indices
Mahmoud H. Mosli et al.
INFLAMMATORY BOWEL DISEASES (2014)
Comparing disease activity indices in ulcerative colitis
A. J. Walsh et al.
JOURNAL OF CROHNS & COLITIS (2014)
Systematic review: Histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative
R. V. Bryant et al.
JOURNAL OF CROHNS & COLITIS (2014)
Review article: newer optical and digital chromoendoscopy techniques vs. dye-based chromoendoscopy for diagnosis and surveillance in inflammatory bowel disease
G. E. Tontini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Histologic Markers of Inflammation in Patients With Ulcerative Colitis in Clinical Remission
Laura Rosenberg et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity
Simon P. L. Travis et al.
GASTROENTEROLOGY (2013)
The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcerative Colitis
Brian G. Feagan et al.
GASTROENTEROLOGY (2013)
Correlation Between the Endoscopic and Histologic Score in Assessing the Activity of Ulcerative Colitis
Bart Lemmens et al.
INFLAMMATORY BOWEL DISEASES (2013)
Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD
Pauliina Molander et al.
JOURNAL OF CROHNS & COLITIS (2013)
P210 Intestinal mucosal calprotectin (iMC) in ulcerative colitis (UC): measuring disease activity, defining remission and predicting outcome
M. Guirgis et al.
Journal of Crohns & Colitis (2013)
European consensus on the histopathology of inflammatory bowel disease
F. Magro et al.
JOURNAL OF CROHNS & COLITIS (2013)
Histological healing in inflammatory bowel disease: A still unfulfilled promise
Vincenzo Villanacci et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing
Talat Bessissow et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
Simon P. L. Travis et al.
GUT (2012)
Mucosal healing in inflammatory bowel diseases: a systematic review
Markus F. Neurath et al.
GUT (2012)
Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation
Judith E. Baars et al.
INFLAMMATORY BOWEL DISEASES (2012)
Recommendations for the treatment of ulcerative colitis with infliximab: A gastroenterology expert group consensus
Walter Reinisch et al.
JOURNAL OF CROHNS & COLITIS (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Review article: defining remission in ulcerative colitis
S. P. L. Travis et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
Jean Frederic Colombel et al.
GASTROENTEROLOGY (2011)
Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease
Marco Daperno et al.
JOURNAL OF CROHNS & COLITIS (2011)
Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease
Laurent Peyrin-Biroulet et al.
JOURNAL OF CROHNS & COLITIS (2011)
Biological and Histological Parameters as Predictors of Relapse in Ulcerative Colitis: A Prospective Study
Sheenam Azad et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2011)
Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2010)
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Filip Baert et al.
GASTROENTEROLOGY (2010)
Mucosal Healing as an Index of Colitis Activity: Back to Histological Healing for Future Indices
Burton I. Korelitz
INFLAMMATORY BOWEL DISEASES (2010)
The pattern and outcome of acute severe colitis
Lotte C. Dinesen et al.
JOURNAL OF CROHNS & COLITIS (2010)
A Systematic Prospective Comparison of Noninvasive Disease Activity Indices in Ulcerative Colitis
Dan Turner et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Severity of Inflammation as a Predictor of Colectomy in Patients With Chronic Ulcerative Colitis
Marco M. Hefti et al.
DISEASES OF THE COLON & RECTUM (2009)
Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2009)
Therapy of ulcerative colitis: state of the art
Oliver Brain et al.
CURRENT OPINION IN GASTROENTEROLOGY (2008)
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial
Geert D'Haens et al.
LANCET (2008)
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: A cohort study
Roopali Bansal Gupta et al.
GASTROENTEROLOGY (2007)
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
Geert D'Haens et al.
GASTROENTEROLOGY (2007)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
P Rutgeerts et al.
GASTROINTESTINAL ENDOSCOPY (2006)
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
M Rutter et al.
GASTROENTEROLOGY (2004)
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis
R Kiesslich et al.
GASTROENTEROLOGY (2003)
Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission
OA Paoluzi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Infliximab for patients with refractory ulcerative colitis
WY Chey
INFLAMMATORY BOWEL DISEASES (2001)
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
A Bitton et al.
GASTROENTEROLOGY (2001)
A reproducible grading scale for histological assessment of inflammation in ulcerative colitis
K Geboes et al.
GUT (2000)
分享论文
